Denali Therapeutics Inc (NASDAQ: DNLI): Reassessing Prospects
Denali Therapeutics Inc (DNLI) concluded trading on Wednesday at a closing price of $13.74, with 3.63 million shares of worth about $49.86 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -52.83% during that period and on April 03, 2025 the price saw a […]
